Manuel Macías-Gonzalez
Manuel Macías-Gonzalez
Dirección de correo verificada de - Página principal
Citado por
Citado por
Melatonin, mitochondria, and cellular bioenergetics
D Acuña‐Castroviejo, M Martin, M Macías, G Escames, J León, H Khaldy, ...
Journal of pineal research 30 (2), 65-74, 2001
Melatonin but not vitamins C and E maintains glutathione homeostasis in t‐butyl hydroperoxide‐induced mitochondrial oxidative stress
M Martín, M Macías, G Escames, J León, D Acuña-Castroviejo
The FASEB journal 14 (12), 1677-1679, 2000
Melatonin‐induced increased activity of the respiratory chain complexes I and IV can prevent mitochondrial damage induced by ruthenium red in vivo
M Martin, M Macias, G Escames, RJ Reiter, MT Agapito, GG Ortiz, ...
Journal of pineal research 28 (4), 242-248, 2000
Melatonin inhibits expression of the inducible NO synthase II in liver and lung and prevents endotoxemia in lipopolysaccharide‐induced multiple organ dysfunction syndrome in rats
E Crespo, M Macías, D Pozo, G Escames, M Martín, F Vives, JM Guerrero, ...
The FASEB Journal 13 (12), 1537-1546, 1999
Melatonin increases the activity of the oxidative phosphorylation enzymes and the production of ATP in rat brain and liver mitochondria
M Martın, M Macıas, J León, G Escames, H Khaldy, D Acuña-Castroviejo
The international journal of biochemistry & cell biology 34 (4), 348-357, 2002
Melatonin counteracts lipopolysaccharide‐induced expression and activity of mitochondrial nitric oxide synthase in rats
G Escames, J León, M Macías, H Khaldy, D Acuña-Castroviejo
The FASEB Journal 17 (8), 1-22, 2003
Preparation of bacterial DNA template by boiling and effect of immunoglobulin G as an inhibitor in real-time PCR for serum samples from patients with brucellosis
MI Queipo-Ortuño, J De Dios Colmenero, M Macias, MJ Bravo, P Morata
Clinical and Vaccine Immunology 15 (2), 293-296, 2008
The obese healthy paradox: is inflammation the answer?
N Barbarroja, R Lopez-Pedrera, MD Mayas, E Garcia-Fuentes, ...
Biochemical Journal 430 (1), 141-149, 2010
Structure-related inhibition of calmodulin-dependent neuronal nitric-oxide synthase activity by melatonin and synthetic kynurenines
J León, M Macías, G Escames, E Camacho, H Khaldy, M Martín, ...
Molecular pharmacology 58 (5), 967-975, 2000
Calreticulin–melatonin: An unexpected relationship
M Macías, G Escames, J Leon, A Coto, Y Sbihi, A Osuna, ...
European journal of biochemistry 270 (5), 832-840, 2003
Study of the potential association of adipose tissue GLP-1 receptor with obesity and insulin resistance
J Vendrell, R El Bekay, B Peral, E García-Fuentes, A Megia, ...
Endocrinology 152 (11), 4072-4079, 2011
Antiobesity effects of the novel in vivo neutral cannabinoid receptor antagonist 5-(4-chlorophenyl)-1-(2, 4-dichlorophenyl)-3-hexyl-1H-1, 2, 4-triazole–LH 21
FJ Pavon, A Bilbao, L Hernández-Folgado, A Cippitelli, N Jagerovic, ...
Neuropharmacology 51 (2), 358-366, 2006
Cohort Profile: Design and methods of the PREDIMED-Plus randomized trial
MA Martínez-González, P Buil-Cosiales, D Corella, M Bulló, M Fitó, ...
International journal of epidemiology 48 (2), 387-388o, 2019
Obesity short‐circuits stemness gene network in human adipose multipotent stem cells
M Roldan, M Macias‐Gonzalez, R Garcia, FJ Tinahones, M Martin
The FASEB Journal 25 (12), 4111-4126, 2011
The role of vitamin D and VDR in carcinogenesis: through epidemiology and basic sciences
BB Merchan, S Morcillo, G Martin-Nunez, FJ Tinahones, ...
The Journal of steroid biochemistry and molecular biology 167, 203-218, 2017
Serum 25-hydroxyvitamin D and adipose tissue vitamin D receptor gene expression: relationship with obesity and type 2 diabetes
M Clemente-Postigo, A Muñoz-Garach, M Serrano, L Garrido-Sánchez, ...
The journal of clinical endocrinology & metabolism 100 (4), E591-E595, 2015
Central versus peripheral antagonism of cannabinoid CB1 receptor in obesity: effects of LH-21, a peripherally acting neutral cannabinoid receptor antagonist, in Zucker rats.
FFR Pavón FJ1, Serrano A, Pérez-Valero V, Jagerovic N, Hernández-Folgado L ...
J Neuroendocrinol 20, 116-123, 2008
Different molecular mechanisms of vitamin D3 receptor antagonists
A Toell, MM Gonzalez, D Ruf, A Steinmeyer, S Ishizuka, C Carlberg
Molecular pharmacology 59 (6), 1478-1485, 2001
The cannabinoid CB1 receptor antagonist SR141716A (Rimonabant) enhances the metabolic benefits of long-term treatment with oleoylethanolamide in Zucker rats
A Serrano, I Del Arco, FJ Pavón, M Macías, V Perez-Valero, ...
Neuropharmacology 54 (1), 226-234, 2008
Mediterranean diet and quality of life: Baseline cross-sectional analysis of the PREDIMED-PLUS trial
I Galilea-Zabalza, P Buil-Cosiales, J Salas-Salvadó, E Toledo, ...
PloS one 13 (6), e0198974, 2018
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20